Clinical Trials Browser

Disease Progression × Nivolumab × Genitourinary × Clear all

NCT04987203 2025-08-22

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Phase 3 Active not recruiting

Carcinoma, Renal Cell, Disease Progression